Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sterilox Technologies was a U.S. medical technology company focused on infection control, sterilization, and disinfection systems for healthcare and related markets. Its core products used a patented electrochemical platform to generate hypochlorous acid-based antimicrobial solutions on site, including the Sterilox Liquid Chemical High Level Disinfectant System for reprocessing heat-sensitive medical devices and the Vashe Wound Cleansing System. The company also marketed related solutions under the Sterilox and Aqualox brands and expanded into food and environmental applications. Sterilox Technologies later became PuriCore, and its healthcare/endoscopy activities and associated technology were subsequently carried forward through successor entities and asset transactions. The company was commercial-stage rather than a drug-development biotech, with value centered on device systems, consumables, and proprietary antimicrobial chemistry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sterilox Technologies.